Verve Therapeutics, Inc. reports

Location
201 Brookline Avenue, Suite 601, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/10/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Sep 9, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 8, 2024
8-K Report | Data 8-K Jun 28, 2024 Jun 26, 2024
8-K/A Report | Data 8-K/A Jun 28, 2024 Jun 6, 2024
SC 13G Report Jun 27, 2024
8-K Report | Data 8-K Jun 7, 2024 Jun 6, 2024
8-K Report | Data 8-K May 31, 2024 May 30, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
8-K Report | Data 8-K May 8, 2024 May 8, 2024
8-K Report | Data 8-K Apr 2, 2024 Apr 2, 2024
10-K Report | Data 10-K Feb 27, 2024 Dec 31, 2023
8-K Report | Data 8-K Feb 27, 2024 Feb 27, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Jan 29, 2024
SC 13G Report Jan 29, 2024
SC 13G/A Report Jan 23, 2024
SC 13G/A Report SC 13G/A Dec 11, 2023
SC 13G/A Report Dec 11, 2023
8-K Report | Data 8-K Nov 29, 2023 Nov 28, 2023
8-K Report | Data 8-K Nov 13, 2023 Nov 12, 2023
10-Q Report | Data 10-Q Nov 7, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 7, 2023 Nov 7, 2023
8-K Report | Data 8-K Oct 23, 2023 Oct 23, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 10, 2023 Aug 10, 2023
8-K Report | Data 8-K Jun 16, 2023 Jun 15, 2023
8-K Report | Data 8-K Jun 15, 2023 Jun 14, 2023
10-Q Report | Data 10-Q May 15, 2023 Mar 31, 2023
8-K Report | Data 8-K May 15, 2023 May 15, 2023
10-K Report | Data 10-K Mar 2, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 2, 2023 Mar 2, 2023
8-K Report | Data 8-K Feb 17, 2023 Feb 14, 2023
SC 13G/A Report 2023 FORM SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G/A(#1E) Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G Report Feb 10, 2023
SC 13G Report SC 13G Feb 10, 2023
SC 13G/A Report Feb 9, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G Report Feb 7, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
8-K Report | Data 8-K Dec 5, 2022 Dec 2, 2022
10-Q Report | Data 10-Q Nov 7, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 7, 2022 Nov 7, 2022
SC 13G/A Report Aug 10, 2022
10-Q Report | Data 10-Q Aug 9, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 9, 2022 Aug 3, 2022
8-K Report | Data 8-K Jul 21, 2022 Jul 20, 2022
8-K Report | Data 8-K Jul 21, 2022 Jul 20, 2022
8-K Report | Data 8-K Jul 20, 2022 Jul 18, 2022
8-K Report | Data 8-K Jul 12, 2022 Jul 12, 2022
8-K Report | Data 8-K Jul 7, 2022 Jul 5, 2022
8-K Report | Data 8-K Jun 13, 2022 Jun 9, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K May 10, 2022 May 10, 2022
10-K Report | Data 10-K Mar 14, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 14, 2022 Mar 14, 2022
SC 13G Report SC 13G Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G Feb 9, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report Jan 24, 2022
SC 13G/A Report 13G/A Dec 28, 2021
8-K Report | Data 8-K Nov 29, 2021 Nov 24, 2021
10-Q Report | Data 10-Q Nov 10, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 10, 2021 Nov 10, 2021
8-K Report | Data 8-K Aug 24, 2021 Aug 19, 2021
10-Q/A Report | Data 10-Q/A Aug 16, 2021 Jun 30, 2021
10-Q Report 10-Q Aug 12, 2021 Jun 30, 2021
8-K Report 8-K Aug 12, 2021 Aug 12, 2021
SC 13G Report SEC SCHEDULE 13G Jun 28, 2021
SC 13G Report Jun 23, 2021
SC 13G Report Jun 23, 2021
8-K Report 8-K Jun 21, 2021 Jun 21, 2021